Published Guidance, NICE advice and quality standards

Skip to filters Skip to results

Showing 11 to 20 of 20

Sort by

colorectal cancerRemove colorectal cancer filter
Type: GuidanceRemove Type: Guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal)	TA240	14 December 2011	29 March 2017
Molecular testing strategies for Lynch syndrome in people with colorectal cancer	DG27	22 February 2017	22 February 2017
Trifluridine–tipiracil for previously treated metastatic colorectal cancer	TA405	24 August 2016	24 August 2016
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)	TA334	25 February 2015	25 February 2015
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	TA307	25 March 2014	25 March 2014
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy	TA242	25 January 2012	25 January 2012
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer	TA118	24 January 2007	1 January 2012
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer	TA212	15 December 2010	15 December 2010
Laparoscopic surgery for colorectal cancer	TA105	23 August 2006	23 August 2006
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer	TA61	27 May 2003	27 May 2003

Results per page

10
25
50
All